A detailed history of Eagle Rock Investment Company, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Eagle Rock Investment Company, LLC holds 49,789 shares of MRK stock, worth $4.95 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
49,789
Previous 50,553 1.51%
Holding current value
$4.95 Million
Previous $6.26 Million 9.65%
% of portfolio
0.97%
Previous 1.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$111.15 - $128.97 $84,918 - $98,533
-764 Reduced 1.51%
49,789 $5.65 Million
Q2 2024

Jul 12, 2024

SELL
$123.8 - $132.96 $381,675 - $409,915
-3,083 Reduced 5.75%
50,553 $6.26 Million
Q1 2024

Apr 15, 2024

SELL
$113.24 - $131.95 $117,316 - $136,700
-1,036 Reduced 1.89%
53,636 $7.08 Million
Q4 2023

Jan 12, 2024

SELL
$100.18 - $109.02 $198,757 - $216,295
-1,984 Reduced 3.5%
54,672 $5.96 Million
Q3 2023

Oct 10, 2023

SELL
$102.95 - $114.33 $231,122 - $256,670
-2,245 Reduced 3.81%
56,656 $5.83 Million
Q2 2023

Jul 19, 2023

SELL
$108.61 - $118.38 $48,874 - $53,271
-450 Reduced 0.76%
58,901 $6.8 Million
Q1 2023

Apr 10, 2023

SELL
$102.94 - $114.86 $325,187 - $362,842
-3,159 Reduced 5.05%
59,351 $6.31 Million
Q4 2022

Jan 25, 2023

BUY
$87.44 - $112.11 $17,225 - $22,085
197 Added 0.32%
62,510 $0
Q3 2022

Nov 08, 2022

SELL
$84.53 - $94.96 $32,374 - $36,369
-383 Reduced 0.61%
62,313 $5.37 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $205,051 - $232,435
-2,456 Reduced 3.77%
62,696 $5.72 Million
Q1 2022

May 11, 2022

SELL
$73.51 - $82.4 $1.69 Million - $1.9 Million
-23,021 Reduced 26.11%
65,152 $5.35 Million
Q4 2021

Feb 17, 2022

BUY
$72.28 - $90.54 $6.37 Million - $7.98 Million
88,173 New
88,173 $6.76 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Eagle Rock Investment Company, LLC Portfolio

Follow Eagle Rock Investment Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Rock Investment Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Rock Investment Company, LLC with notifications on news.